1. Home
  2. OMC vs WAT Comparison

OMC vs WAT Comparison

Compare OMC & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Omnicom Group Inc.

OMC

Omnicom Group Inc.

HOLD

Current Price

$69.54

Market Cap

24.2B

ML Signal

HOLD

Logo Waters Corporation

WAT

Waters Corporation

HOLD

Current Price

$383.32

Market Cap

22.5B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
OMC
WAT
Founded
1944
1958
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Laboratory Analytical Instruments
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
24.2B
22.5B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
OMC
WAT
Price
$69.54
$383.32
Analyst Decision
Buy
Buy
Analyst Count
6
17
Target Price
$92.83
$395.00
AVG Volume (30 Days)
4.1M
562.0K
Earning Date
02-04-2026
02-12-2026
Dividend Yield
4.58%
N/A
EPS Growth
N/A
3.82
EPS
6.79
10.88
Revenue
$16,065,300,000.00
$3,105,638,000.00
Revenue This Year
$4.67
$7.96
Revenue Next Year
$40.06
$6.39
P/E Ratio
$10.30
$35.06
Revenue Growth
4.13
6.90
52 Week Low
$66.34
$275.05
52 Week High
$89.27
$417.10

Technical Indicators

Market Signals
Indicator
OMC
WAT
Relative Strength Index (RSI) 30.91 43.66
Support Level $66.33 $373.40
Resistance Level $70.85 $389.82
Average True Range (ATR) 2.21 9.53
MACD -1.19 -1.45
Stochastic Oscillator 18.68 29.87

Price Performance

Historical Comparison
OMC
WAT

About OMC Omnicom Group Inc.

Omnicom is a holding company that owns several advertising agencies and related firms. It provides traditional and digital advertising services that include creative design, market research, data analytics, ad placement, and public relations. The firm operates globally, providing services in more than 70 countries; it generates more than one half of its revenue in North America and nearly 30% in Europe.

About WAT Waters Corporation

Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.

Share on Social Networks: